Zacks Research Estimates TriMas' Q3 Earnings (NASDAQ:TRS)

Key Points

• Zacks Research has increased its Q3 earnings estimate for TriMas to $0.54 per share, up from a previous estimate of $0.52.
• TriMas has a current dividend yield of 0.4% with an annualized dividend of $0.16 per share.
• Analysts have set a target price of $45.00 for TriMas stock, reflecting positive sentiment towards the company's future performance.

TriMas Corporation (NASDAQ:TRS - Free Report) - Equities research analysts at Zacks Research lifted their Q3 2025 earnings per share (EPS) estimates for TriMas in a note issued to investors on Tuesday, August 12th. Zacks Research analyst M. Das now forecasts that the industrial products company will post earnings per share of $0.54 for the quarter, up from their previous forecast of $0.52. The consensus estimate for TriMas' current full-year earnings is $1.69 per share. Zacks Research also issued estimates for TriMas' FY2025 earnings at $1.95 EPS and Q4 2026 earnings at $0.38 EPS.

TriMas (NASDAQ:TRS - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The industrial products company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.11. TriMas had a return on equity of 11.49% and a net margin of 3.83%. The firm had revenue of $274.76 million for the quarter, compared to analysts' expectations of $251.18 million. During the same period last year, the business posted $0.43 earnings per share. The firm's revenue for the quarter was up 14.2% on a year-over-year basis.

Several other equities research analysts have also weighed in on the company. KeyCorp set a $45.00 target price on TriMas and gave the stock an "overweight" rating in a research report on Tuesday. BWS Financial reissued a "buy" rating and set a $45.00 price target (up from $40.00) on shares of TriMas in a report on Wednesday, July 30th. Finally, Wall Street Zen raised TriMas from a "hold" rating to a "buy" rating in a report on Sunday, June 1st.

TriMas Stock Performance

NASDAQ TRS traded down $0.20 during trading hours on Wednesday, hitting $36.77. The company had a trading volume of 397,269 shares, compared to its average volume of 541,169. TriMas has a fifty-two week low of $19.33 and a fifty-two week high of $37.49. The company has a quick ratio of 1.44, a current ratio of 2.59 and a debt-to-equity ratio of 0.59. The business has a fifty day simple moving average of $30.89 and a 200-day simple moving average of $26.05. The firm has a market cap of $1.49 billion, a P/E ratio of 40.41 and a beta of 0.66.

TriMas Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, August 12th. Investors of record on Tuesday, August 5th were issued a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend was Tuesday, August 5th. TriMas's payout ratio is presently 17.58%.

Insider Transactions at TriMas

In other news, Director Adrianne Shapira bought 4,000 shares of the stock in a transaction that occurred on Thursday, June 5th. The shares were purchased at an average cost of $25.82 per share, with a total value of $103,280.00. Following the completion of the acquisition, the director directly owned 8,476 shares in the company, valued at approximately $218,850.32. The trade was a 89.37% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Shawn Sedaghat bought 410,172 shares of the stock in a transaction that occurred on Wednesday, May 21st. The shares were purchased at an average cost of $25.43 per share, for a total transaction of $10,430,673.96. Following the completion of the acquisition, the director owned 1,810,821 shares of the company's stock, valued at $46,049,178.03. This trade represents a 29.28% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders have purchased 848,232 shares of company stock worth $21,644,995. 14.20% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. Captrust Financial Advisors acquired a new position in shares of TriMas in the 2nd quarter valued at $355,000. Tidal Investments LLC acquired a new position in shares of TriMas in the 2nd quarter valued at $220,000. Man Group plc acquired a new position in shares of TriMas in the 2nd quarter valued at $294,000. Lazard Asset Management LLC boosted its position in shares of TriMas by 4,559.3% in the 2nd quarter. Lazard Asset Management LLC now owns 101,154 shares of the industrial products company's stock valued at $2,894,000 after purchasing an additional 98,983 shares during the period. Finally, HRT Financial LP boosted its position in shares of TriMas by 208.2% in the 2nd quarter. HRT Financial LP now owns 54,170 shares of the industrial products company's stock valued at $1,549,000 after purchasing an additional 36,591 shares during the period. 99.42% of the stock is owned by institutional investors and hedge funds.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.